Risk for symptomatic embolism can be predicted via echocardiographic vegetation features in patients with infective endocarditis.

In this final PMA module, Instylla has submitted clinical study resultsto the FDA, advancing our pursuit of the indication ...

Cordis Angioguard RX Emboli Capture Guidewire System Filter Distal Indicated for use as a guidewire and EPS to contain and remove embolic material (thrombus/debris) while performing carotid artery ...

Instylla, Inc. announced that it recently submitted the final module of its premarket approval (PMA) application to the FDA ...

Instylla, Inc. is a privately held company based in Bedford, MA, focused on developing novel resorbable embolic agents to advance interventional radiology, with initial clinical applications in ...

Background Arteriovenous malformations (AVMs) are vascular lesions that may be treated by an endovascular approach using liquid embolic agents but the control of the liquid embolic agent remains poor ...

A risk-assessment tool incorporating NT-proBNP and high-sensitivity troponin performs better than clinical scores for ...

Safety and Excellent Pain Relief Effect after Musculoskeletal Pain Embolization SEOUL, South Korea, /PRNewswire/ -- NEXTBIOMEDICAL CO., LDT, announced that clinical study results of Nexsphere-F™, a ...

Protembis, a privately-held emerging cardiovascular medical device company, announced today the establishment of a Scientific ...

Background Onyx is frequently used for endovascular embolization of intracranial arteriovenous malformations (AVMs) and dural arteriovenous fistulas (dAVFs). One drawback of using Onyx is the ...